Karassa FB - Search Results

1

Meta-analysis of the association between low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoimmune disease.

Trikalinos TA, Karassa FB, Ioannidis JP. Trikalinos TA, et al. Among authors: karassa fb. Blood. 2001 Sep 1;98(5):1634-5. doi: 10.1182/blood.v98.5.1634. Blood. 2001. PMID: 11547773 Free article. No abstract available.

2

Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.

Karassa FB, Trikalinos TA, Ioannidis JP; FcgammaRIIa-SLE Meta-Analysis Investigators. Karassa FB, et al. Arthritis Rheum. 2002 Jun;46(6):1563-71. doi: 10.1002/art.10306. Arthritis Rheum. 2002. PMID: 12115187 Free article.

3

The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.

Karassa FB, Trikalinos TA, Ioannidis JP. Karassa FB, et al. Biomed Pharmacother. 2004 Jun;58(5):286-91. doi: 10.1016/j.biopha.2004.04.004. Biomed Pharmacother. 2004. PMID: 15194164

4

The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis.

Karassa FB, Trikalinos TA, Ioannidis JP; Fc gamma RIIIA-SLE meta-analysis investigators. Karassa FB, et al. Kidney Int. 2003 Apr;63(4):1475-82. doi: 10.1046/j.1523-1755.2003.00873.x. Kidney Int. 2003. PMID: 12631364 Free article.

5

Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.

Karassa FB, Bijl M, Davies KA, Kallenberg CG, Khamashta MA, Manger K, Michel M, Piette JC, Salmon JE, Song YW, Tsuchiya N, Yoo DH, Ioannidis JP. Karassa FB, et al. Arthritis Rheum. 2003 Jul;48(7):1930-8. doi: 10.1002/art.11059. Arthritis Rheum. 2003. PMID: 12847687 Free article.

6

Bias in uncontrolled therapeutic trials in rheumatology due to selection of populations with extreme characteristics.

Ioannidis JP, Karassa FB. Ioannidis JP, et al. Among authors: karassa fb. J Rheumatol. 2001 Aug;28(8):1881-7. J Rheumatol. 2001. PMID: 11508595

7

Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.

Karassa FB, Tatsioni A, Ioannidis JP. Karassa FB, et al. J Rheumatol. 2003 May;30(5):979-84. J Rheumatol. 2003. PMID: 12734892

8

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus.

Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, Moutsopoulos HM. Karassa FB, et al. Am J Med. 2000 Dec 1;109(8):628-34. doi: 10.1016/s0002-9343(00)00603-3. Am J Med. 2000. PMID: 11099682

9

Mortality in systemic sclerosis.

Karassa FB, Ioannidis JP. Karassa FB, et al. Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S85-93. Clin Exp Rheumatol. 2008. PMID: 19026149 Review.

10

Risk factors for central nervous system involvement in systemic lupus erythematosus.

Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM. Karassa FB, et al. QJM. 2000 Mar;93(3):169-74. doi: 10.1093/qjmed/93.3.169. QJM. 2000. PMID: 10751236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters